AffordableGLP-1Providers Take the quiz
Methodology · published in advance

How this site verifies, restates, and ranks

Released: · Last reviewed:

Every editorial rule here was written before any ranking was assigned, and applies unchanged to every program — including any provider whose links may earn this site a commission. This is the page every number on the site ultimately answers to.

0 · Ranking methodology v4.1 (criteria published November 20, 2026)

Overall rankings use seven weighted categories totalling 100 points. Each category is scored only from what a program publishes on its own pages, read on the date shown; anything not stated scores zero.

  • Pricing transparency (20): 4 points each for a printed month-to-month price; every plan length priced with its billing basis (monthly or up front) stated without contradiction; the dose policy stated; membership and fees stated; and a headline price that is not a sale or “starting at” figure without a term.
  • Total annual cost (20): the lowest 12-month cost of compounded tirzepatide the program’s printed terms allow, membership included. The lowest in the scored set earns 20 and the others earn 20 × (lowest ÷ theirs). A sale price with no stated end is counted at the list price it prints; if no regular price is printed, the cost cannot be computed and scores 0.
  • Clinical oversight (15): 5 each for a stated licensed-prescriber review, a named medical group or medical director, and included clinician follow-up or messaging.
  • Pharmacy transparency (15): 10 for naming the dispensing pharmacy or pharmacies; 5 for stating the pharmacy type (503A or 503B).
  • Support (10): 5 for a stated support channel; 5 for coaching or nutrition support included in the price.
  • Regulatory disclosure (10): 5 for stating that compounded drugs are not FDA-approved; 5 when we found no FDA warning letter to the company dated in the past 12 months (FDA warning-letter pages and name searches, read on the scoring date). A letter costs these points until FDA publishes a close-out letter. On November 20, 2026 we checked all eight scored programs against FDA’s warning-letter index (114 telehealth letters, none closed out): NexLife (730096) and Eden (728279) have letters dated June 8, 2026; the other six have none.
  • Accessibility (10): 4 for publishing the states served without contradiction; 3 for HSA/FSA or pay-later options; 3 for no required membership.

Computed on November 20, 2026 for the eight programs on our homepage: NexLife 81.9, Ozari Health 81.7, Collective 72, Eden 64.3, Mondae 63, SnagRx 55.9, Embody 49.4 (scored from its October 15 read) and WellMedr 44. The evidence behind every point is in the standings table. NexLife is also our editor’s pick, an editorial label shown separately from the computed scores; the 94/100 shown for NexLife before November 20, 2026 was not computed against other programs and is withdrawn. Programs we have not scored are listed A–Z, never ranked. Price pages also apply five price checks a reader can verify: billed by the month, medication and care in one price, the same price at every dose, no membership fee, and a price read by us on the seller’s page. Sorted price tables are ordered by price alone, so a lower-priced program appears above NexLife whenever it costs less.

Every page is researched by Dr. Parmis (Medical Researcher, Western University of Health Sciences) and medically reviewed by Dr. Jonathan Snipes, MD (NPI 1821250077) and Kim Callender, NP (FNP-BC, NPI 1144661760).

1 · Restatement: one unit for every price

Sellers quote in whatever unit flatters them: 4-week cycles, calendar months, quarters, prepaid years, first-month promos. We convert everything to a true month of 30.4375 days before comparing. The math is one line — price ÷ days in the billing cycle × 30.4375 — and it changes real rankings: a "$249/month" billed every 28 days is $270.68 per true month and $3,247 a year, because that cycle bills 13.04 times annually. Where a rate requires prepayment (an annual plan billed up front), we say so next to the number rather than letting it pose as a monthly price.

2 · Provenance: three tiers, never blurred

First-party means we walked the seller's own published pages on a stated date and recorded what they said, with the URL. Reported means a third-party tracker published the figure with its own check date; we cite the tracker and the date, and queue the program for first-party verification. Queued means tracked with no defensible number yet — the program appears in the roster, not in ranked tables. A Reported figure is never promoted to Verified by the passage of time, only by our own dated check. And a Verified figure ages out: past 90 days it is flagged stale in the API and drops from the verified totals until a fresh dated check restores it.

3 · Conflicts: shown, not averaged

When sources disagree — one tracker reports $179 while another reports $349–$449 for the same program — we print both with their dates and flag the row. Averaging conflicting reports manufactures a number nobody published; showing them tells the reader the one true thing we know, which is that the price is unstable or basis-dependent.

4 · Price checks: five structures we can verify

The overall order on ranked pages comes from the v4.1 scores in Section 0. Price pages add five checks that can be verified on a seller's own pages: the billing calendar (calendar-month beats 4-week), all-in clarity (one number covering medication, consults and shipping), the dose-ladder policy (flat at every dose beats entry-dose bait), membership fees ($0 beats stacked), and provenance (verified beats reported). We do not publish invented editorial scores — no "8.2/10" for a checkout we haven't walked — and service-quality scoring waits until we have first-party evidence to score.

4b · Verified floor vs. verified standing rate (added September 2026)

Two of the cheapest first-party-verified prices on the market are conditional: a twelve-month supply paid at once with all sales final, and a promotional month-to-month rate limited to the period stated at checkout. Sticker tables keep sorting every program by its own lowest published figure — those rows sit on top, with a structural flag computed from the row's fields (promotional rate, prepaid · all sales final, term prepaid). Every "lowest first-party-verified" sentence on the site is generated by one function and states two numbers: the verified floor with its condition, and the verified standing rate — the lowest figure that is billed monthly, with no promotion and no prepayment, medication included. The editor’s-pick bar shows NexLife, our editorial pick, which also ranks first on the computed v4.1 scores of November 20, 2026; the best-providers standings break ties on the five checks toward a standing rate before a conditional one, then toward the lower figure. Where a program's month-to-month rate is standing but its multi-month terms are prepaid, the month-to-month rate is its standing rate.

5 · The commission firewall

This site may earn a commission when a reader signs up through a link to any provider it lists — stated on the ownership & funding page. A commission cannot buy a slot or a score: the computed scores follow the criteria in Section 0, which apply unchanged to every program, and the editor’s pick is an editorial label shown separately from them.

What the status labels mean. Verified: this desk loaded the provider’s live first-party page on the date shown and captured the represented price and terms — intro versus renewal, membership, billing interval, commitment, and offer conditions where they exist. It verifies what the provider publicly represents; it does not independently validate medical, testing, or pharmacy-licensure claims, which stay labeled provider-stated until checked against regulators or documents. Reported: a third-party source or a conflicting first-party page, carried with provenance and date. Statuses moved in bulk exactly once — on the 2026-08-25 first-party verification report — and every field change is in the public change history beside the dataset.

6 · Health claims and citations

Clinical statements cite the primary source (trial name, registry, or FDA document) and are checked by a human before publication; drafts produced with AI assistance are marked internally and verified against PubMed and fda.gov before going live. We name what compounded products are — not FDA-approved, not therapeutically equivalent to brands — on every page where a price appears. A page shows “Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC)” with the date of their last review of that page; pages not revised since keep their earlier review date.

7 · Freshness and the change log

NexLife's plan pages and the other verified rows are re-read at each update, and a row's verified date moves only when the read succeeds; verified rows expire after 90 days and drop from the verified totals until rechecked; money pages are otherwise re-checked on a 30-day cadence or when a reader flags a change; every check updates the visible date on the row it touched. Page dates are honest by construction: a page's published date never moves, and its modified date (and sitemap lastmod) moves only when the page's content changed — a rebuild that changes nothing is not an update. The JSON mirror of the dataset lives at /api/prices.json, regenerated with every build; a public change history (date, provider, field, old → new, source) ships alongside it. Errors are handled under the corrections policy — corrected in place, noted at the bottom of the page, never silently.

What we don't do

No availability claims without a source. No "N providers ship to your state" headlines built from scraped rosters. No fabricated reviewer identities. No averaging of conflicting prices. No use of the word "independent" to describe this site while a provider relationship exists — the honest terms are reader-supported and affiliate-supported, with the relationship disclosed.

Researched By

Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.